Pages that link to "Q40364356"
Jump to navigation
Jump to search
The following pages link to Proteomic evidence for roles for nucleolin and poly[ADP-ribosyl] transferase in drug resistance (Q40364356):
Displaying 12 items.
- Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin (Q28472975) (← links)
- Discovery of IL-18 as a novel secreted protein contributing to doxorubicin resistance by comparative secretome analysis of MCF-7 and MCF-7/Dox (Q28477021) (← links)
- The histone variant MacroH2A1 regulates target gene expression in part by recruiting the transcriptional coregulator PELP1. (Q33743684) (← links)
- Immunophenotypic predictive profiling of BRCA1-associated breast cancer (Q34467646) (← links)
- Use of comparative proteomics to identify potential resistance mechanisms in cancer treatment (Q36388185) (← links)
- Breast cancer proteomics: clinical perspectives. (Q36717346) (← links)
- Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer (Q37277677) (← links)
- Mass spectrometry-based functional proteomics of poly(ADP-ribose) polymerase-1. (Q37956668) (← links)
- PARP-1 expression in breast cancer including BRCA1-associated, triple negative and basal-like tumors: possible implications for PARP-1 inhibitor therapy (Q39575484) (← links)
- Proteomic approaches for investigation of therapy resistance in cancer (Q39959305) (← links)
- Proteome characterization of a human urothelial cell line resistant to the bladder carcinogen 4-aminobiphenyl (Q40137535) (← links)
- Contribution of proteomics to the study of the role of cytokeratins in disease and physiopathology (Q53898691) (← links)